• Citer

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled trial

par Mease, Philip P.J.;Gladman, Dafna D.D.;Ritchlin, Christopher C.T.;Ruderman, Eric E.M.;Steinfeld, Serge ;Choy, Ernest;Sharp, John J.T.;Ory, Peter P.A.;Perdok, Renee R.J.;Weinberg, Mark M.A.
Référence Arthritis and rheumatism, 52, 10, page (3279-3289)
Publication Publié, 2005-10

Article révisé par les pairs

• Détails
• Contenu

Titre:	Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled trial
Auteur:	Mease, Philip P.J.; Gladman, Dafna D.D.; Ritchlin, Christopher C.T.; Ruderman, Eric E.M.; Steinfeld, Serge; Choy, Ernest; Sharp, John J.T.; Ory, Peter P.A.; Perdok, Renee R.J.; Weinberg, Mark M.A.
Informations sur la publication:	Arthritis and rheumatism, 52, 10, page (3279-3289)
Statut de publication:	Publié, 2005-10
Sujet CREF:	Allergie et immunopathologie
	Pharmacologie
	Rhumatologie
	Immunologie
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0004-3591
	info:doi/10.1002/art.21306
	info:scp/26844432745
	info:pmid/16200601